FDA product code NAJ: Agents, Embolic, For Treatment Of Uterine Fibroids
NAJ is the FDA product code for agents, embolic, for treatment of uterine fibroids. It is a Class II device, regulated under 21 CFR 870.3300 and reviewed by the Obstetrics and Gynecology panel. FDA has cleared 8 510(k) submissions under NAJ, 1 in the last five years, from 7 different applicants. The average 510(k) review took 141 days (median 153). FDA has posted 1 recall for NAJ devices.
Classification
| Field | Value |
|---|---|
| Device name | Agents, Embolic, For Treatment Of Uterine Fibroids |
| Device class | Class II |
| Regulation | 21 CFR 870.3300 |
| Review panel | OB — Obstetrics and Gynecology |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for NAJ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2018 | 1 | 271 |
| 2023 | 1 | 21 |
Compare with all 510(k) review times · Search every NAJ clearance
Top NAJ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Merit Medical Systems, Inc. | 2 | 2023-12-21 |
| Suzhou Hengrui Callisyn Biomedical Co., Ltd. | 1 | 2018-09-17 |
| Celonova Biosciences, Inc. | 1 | 2014-02-24 |
| Boston Scientific Corporation | 1 | 2010-04-16 |
| Cook Incorporated | 1 | 2008-12-23 |
2 more applicants have NAJ clearances. See the full list in Caduvo.
Most recent NAJ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K233813 | Merit Medical Systems, Inc. | Bearing nsPVA Express | 2023-12-21 | 21 |
| K173871 | Suzhou Hengrui Callisyn Biomedical Co., Ltd. | CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres | 2018-09-17 | 271 |
| K133447 | Celonova Biosciences, Inc. | EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERES | 2014-02-24 | 104 |
| K130259 | Merit Medical Systems, Inc. | BEARING NSPVA EMBOLIZATION PARTICLES | 2013-06-07 | 126 |
| K100663 | Boston Scientific Corporation | CONTOUR EMBOLIZATION PARTICLES, MODELS M0017600121, M0017600221, M0017600321 | 2010-04-16 | 39 |
Recalls for NAJ devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2009-08-17.
Frequently asked questions
What is FDA product code NAJ?
NAJ is the FDA product code for agents, embolic, for treatment of uterine fibroids. It is a Class II device, regulated under 21 CFR 870.3300 and reviewed by the Obstetrics and Gynecology panel.
What device class is NAJ?
Class II, regulation 21 CFR 870.3300. Typical premarket route: 510(k).
How long does a 510(k) take for product code NAJ?
Across 8 cleared submissions the average was 141 days from receipt to decision (median 153).
Which companies have the most NAJ clearances?
Merit Medical Systems, Inc. (2); Suzhou Hengrui Callisyn Biomedical Co., Ltd. (1); Celonova Biosciences, Inc. (1); Boston Scientific Corporation (1); Cook Incorporated (1).
Have NAJ devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2009-08-17.
Next steps
- Run an FDA pathway report with predicate devices for product code NAJ
- Run a recall and safety report across every NAJ manufacturer
- Watch product code NAJ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Obstetrics and Gynecology product codes · FDA product code lookup · 510(k) database search · 510(k) review times